Additionally, the calcified lower limb arteries of T2D patients (n = 7) exhibited a significant upregulation of sclerostin mRNA compared to the non-calcified lower limb arteries of healthy controls (n = 3), with a 4.71-fold increase (p = 0.010) (Fig. 4F). The gene discussed is SOST; the disease is type 2 diabetes mellitus.